High incidence of aseptic hip necrosis in Hodgkin lymphoma patients treated with escalated BEACOPP receiving methylprednisolone.

Sandra Basic-KindaIvan KarlakNadira DurakovićZvonimir I LubinaIvo Livaja RadmanSnježana DotlicZinaida PericIda HudeIgor Aurer

Published in: Internal medicine journal (2018)

The use of methylprednisolone was shown to be a risk factor for the development of AVN in patients treated with eBEACOPP and should not be the corticosteroid of choice in the treatment of patients with HL.

Keyphrases

hodgkin lymphoma
high dose
risk factors
low dose
total hip arthroplasty
combination therapy
decision making